Linked Life Data

15947545

Source:http://linkedlifedata.com/resource/pubmed/id/15947545

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2005-6-10
pubmed:abstractText
Cancer is a leading cause of death in developed countries. For most cancers, a patient's prognosis improves dramatically when the disease is detected at an early stage. Although advancements in imaging technology have dramatically improved early detection, many cancers go undetected until it is too late. As cancer develops, molecular changes occur before many of the current prognostic markers can be detected. Proteomics will be used to interrogate the protein milieu in serum and urine to detect molecular changes indicative of a disease state and will provide a cost-effective alternative to current diagnostic tools.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0954-691X
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
701-3
pubmed:dateRevised
2009-10-16
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
The promising future of proteomics in cancer diagnosis and treatment.
pubmed:affiliation
Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR 97239, USA.
pubmed:publicationType
Journal Article, Comment